Vanda Pharmaceuticals | VNDA - Rentabilidad Por Dividendo

Precio De Mercado
7.15
Cambio Diario
0.33 4.77%
Mensual
-16.92%
Anual
49.79%
Q1 Expectativa
6.91




Dy Cambio Fecha
Akebia Therapeutics 0 0 2025-03
Anika Therapeutics 0 0 2025-03
AstraZeneca USD 1.74 0.4 2025-12
Bristol-Myers Squibb 0.22 0.04 2025-12
Eli Lilly 0.58 0.16 2025-12
Enanta Pharmaceuticals 0 0 2025-03
Esperion Therapeutics 0 0 2025-03
Heron Therapeutics 0 0 2025-03
J&J 2.5 0.32 2025-12
Lexicon Pharmaceuticals 0 0 2025-03
Merck 3.12 0.74 2025-12
Minerva Neurosciences 0 0 2025-03
Novartis 2.9 0.22 2025-12
Pfizer 6.91 0.33 2025-12
Puma Biotechnology 0 0 2025-03
Sangamo BioSciences 0 0 2025-03
Sanofi 4.74 0.25 2025-12
Takeda 4.08 0.46 2025-12
Vanda Pharmaceuticals 0 0 2025-03